
Hilary Billington's plan to boost opportunities for women cyclists

Mono sidelines Gunn-Rita's training partner

Go nuts for women's cycling!

Rusch, Smith recall the highs and lows of six days in the Patagonian wilderness
Dutchman out of Cadel Evans' squad
Thomas Dekker has tested positve for blood boster EPO in a re-test of a December 2007 doping control. He has been placed on non-active status and removed from the Silence-Lotto Tour de France team, the team announced Wednesday afternoon.
Charley Wegelius will take his place on the Tour team.
Dekker underwent an out-of-competition doping control in December 2007, while he was under contract with Rabobank. That control was negative, but because his blood values throughout 2008 were suspicious, the World Anti-Doping Agency retested that December 2007 control. Using new testing methods, the sample showed the presence of EPO.
"I am extremely disappointed," said team manager Marc Sergeant. "This happened when Dekker was riding for Rabobank, but the news is no less hard."
Dekker left Rabobank the middle of last season under unexplained circumstances.
Follow Cyclingnews on Twitter for the very latest coverage of events taking place in the cycling world - twitter.com/cyclingnewsfeed